318 related articles for article (PubMed ID: 22652964)
1. Nucleoside-5'-phosphorothioate analogues are biocompatible antioxidants dissolving efficiently amyloid beta-metal ion aggregates.
Amir A; Shmuel E; Zagalsky R; Sayer AH; Nadel Y; Fischer B
Dalton Trans; 2012 Jul; 41(28):8539-49. PubMed ID: 22652964
[TBL] [Abstract][Full Text] [Related]
2. Soluble amyloid beta1-28-copper(I)/copper(II)/Iron(II) complexes are potent antioxidants in cell-free systems.
Baruch-Suchodolsky R; Fischer B
Biochemistry; 2008 Jul; 47(30):7796-806. PubMed ID: 18598056
[TBL] [Abstract][Full Text] [Related]
3. Rapid exchange of metal between Zn(7)-metallothionein-3 and amyloid-β peptide promotes amyloid-related structural changes.
Pedersen JT; Hureau C; Hemmingsen L; Heegaard NH; Østergaard J; Vašák M; Faller P
Biochemistry; 2012 Feb; 51(8):1697-706. PubMed ID: 22283439
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside-2',3'/3',5'-bis(thio)phosphate antioxidants are also capable of disassembly of amyloid beta42-Zn(ii)/Cu(ii) aggregates via Zn(ii)/Cu(ii)-chelation.
Hevroni BL; Major DT; Dixit M; Mhashal AR; Das S; Fischer B
Org Biomol Chem; 2016 May; 14(20):4640-53. PubMed ID: 27109038
[TBL] [Abstract][Full Text] [Related]
5. Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease.
Huang L; Lu C; Sun Y; Mao F; Luo Z; Su T; Jiang H; Shan W; Li X
J Med Chem; 2012 Oct; 55(19):8483-92. PubMed ID: 22978824
[TBL] [Abstract][Full Text] [Related]
6. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
7. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
Baruch-Suchodolsky R; Fischer B
Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
[TBL] [Abstract][Full Text] [Related]
8. Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer.
Faller P
Chembiochem; 2009 Dec; 10(18):2837-45. PubMed ID: 19877000
[TBL] [Abstract][Full Text] [Related]
9. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
10. NMR studies of zinc, copper, and iron binding to histidine, the principal metal ion complexing site of amyloid-beta peptide.
Nair NG; Perry G; Smith MA; Reddy VP
J Alzheimers Dis; 2010; 20(1):57-66. PubMed ID: 20164601
[TBL] [Abstract][Full Text] [Related]
11. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
12. [Cu2+ and Zn2+-induced aggregation of amyloid-beta peptide].
Zhang Y; Zhu JM; Liu CL
Yao Xue Xue Bao; 2012 Mar; 47(3):399-404. PubMed ID: 22645766
[TBL] [Abstract][Full Text] [Related]
13. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
14. Quenched hydrogen/deuterium exchange NMR characterization of amyloid-beta peptide aggregates formed in the presence of Cu2+ or Zn2+.
Olofsson A; Lindhagen-Persson M; Vestling M; Sauer-Eriksson AE; Ohman A
FEBS J; 2009 Aug; 276(15):4051-60. PubMed ID: 19549187
[TBL] [Abstract][Full Text] [Related]
15. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
[TBL] [Abstract][Full Text] [Related]
16. Zinc-mediated modulation of the configuration and activity of complexes between copper and amyloid-β peptides.
Liu L; Xia N
Biochem Biophys Res Commun; 2012 Jan; 417(1):153-6. PubMed ID: 22138653
[TBL] [Abstract][Full Text] [Related]
17. pH-dependent kinetics of copper ions binding to amyloid-β peptide.
Bin Y; Chen S; Xiang J
J Inorg Biochem; 2013 Feb; 119():21-7. PubMed ID: 23174653
[TBL] [Abstract][Full Text] [Related]
18. Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease.
Lakatos A; Zsigó E; Hollender D; Nagy NV; Fülöp L; Simon D; Bozsó Z; Kiss T
Dalton Trans; 2010 Feb; 39(5):1302-15. PubMed ID: 20104357
[TBL] [Abstract][Full Text] [Related]
19. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
[TBL] [Abstract][Full Text] [Related]
20. Nucleoside-2',3'/3',5'-bis(thio)phosphate analogues are promising antioxidants acting mainly via Cu+/Fe2+ ion chelation.
Hevroni BL; Sayer AH; Blum E; Fischer B
Inorg Chem; 2014 Feb; 53(3):1594-605. PubMed ID: 24410662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
